Table 2.
Clinical characteristics and outcome of the patients with positive small bowel capsule
| Case | Sex | Age | SBCE Findings | LS | Treatment pre-SBCE | Treatment post-SBCE | Diagnostic at follow-up |
| 1 | F | 38 | Multiple jejuno-ileal ulcerations | 1404 | 5ASA | 5 ASA + AZT | CD |
| 2 | F | 18 | Ulcer (n = 1) and edema of 3° tertile | 143 | AZT | Anti-TNF | CD |
| 3 | M | 23 | Ulcer (n = 1) and edema of 3° tertile | 143 | 5ASA | 5ASA | CD |
| 4 | F | 20 | Ulcerations (n = 2) and edema of 3° tertile | 233 | 5ASA | 5ASA | CD |
| 5 | F | 33 | Ulcer (n = 3) of 2° tertile | 225 | 5ASA | 5ASA | CD |
| 6 | F | 19 | Multiple ulcerations and edema of 3° tertile | 908 | 5ASA | AZT | CD |
| 7 | M | 60 | Focal edema of 1° tertile | 8 | No treatment | 5ASA | UC |
| 8 | M | 22 | Multiple jejuno-ileal ulcerations | 2080 | 5ASA | 5ASA + AZT | CD |
| 9 | F | 32 | Multiple ulcerations and edema of 3° tertile | 908 | 5ASA | AZT | CD |
| 10 | F | 27 | Focal edema of 3° tertile | 8 | Prednisolone | anti-TNF | UC |
| 11 | F | 47 | Focal edema of 2° tertile | 8 | 5ASA | 5ASA | UC |
| 12 | F | 31 | Ulceration and edema of 1° (n = 5) and 2° tertile (n = 6) | 879 | 5ASA+Prednisolone | AZT | CD |
| 13 | M | 44 | Focal edema of 3º tertile | 8 | 5ASA | 5ASA | UC |
5ASA: Mesalamine; anti-TNF: Anti-tumor necrosis factor drug; AZT: Azathioprine; CD: Crohn’s disease; SBCE: Small bowel capsule endoscopy; LS: Lewis score; UC: Ulcerative colitis.